Stifel Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Buy
49,704
+3,889
+8% +$94.7K ﹤0.01% 2202
2025
Q1
$951K Sell
45,815
-446
-1% -$9.26K ﹤0.01% 2267
2024
Q4
$1.09M Sell
46,261
-18,124
-28% -$427K ﹤0.01% 2196
2024
Q3
$1.65M Sell
64,385
-1,087
-2% -$27.8K ﹤0.01% 1897
2024
Q2
$1.54M Sell
65,472
-1,479
-2% -$34.7K ﹤0.01% 1906
2024
Q1
$1.93M Sell
66,951
-1,322
-2% -$38K ﹤0.01% 1750
2023
Q4
$2.24M Buy
68,273
+2,166
+3% +$71.1K ﹤0.01% 1586
2023
Q3
$1.84M Buy
66,107
+233
+0.4% +$6.49K ﹤0.01% 1647
2023
Q2
$2.25M Buy
65,874
+697
+1% +$23.8K ﹤0.01% 1551
2023
Q1
$1.96M Sell
65,177
-3,024
-4% -$90.9K ﹤0.01% 1579
2022
Q4
$1.93M Sell
68,201
-4,618
-6% -$130K ﹤0.01% 1550
2022
Q3
$2.39M Buy
72,819
+7,470
+11% +$246K ﹤0.01% 1340
2022
Q2
$2.06M Buy
65,349
+18,564
+40% +$585K ﹤0.01% 1476
2022
Q1
$2.15M Sell
46,785
-11,099
-19% -$510K ﹤0.01% 1568
2021
Q4
$3.55M Sell
57,884
-13,242
-19% -$811K ﹤0.01% 1253
2021
Q3
$5.32M Buy
71,126
+3,634
+5% +$272K 0.01% 990
2021
Q2
$6.24M Sell
67,492
-28,815
-30% -$2.67M 0.01% 903
2021
Q1
$8.55M Buy
96,307
+37,053
+63% +$3.29M 0.01% 716
2020
Q4
$5.53M Buy
59,254
+12,408
+26% +$1.16M 0.01% 836
2020
Q3
$2.98M Sell
46,846
-6,617
-12% -$421K 0.01% 1010
2020
Q2
$2.79M Buy
53,463
+30,156
+129% +$1.57M 0.01% 987
2020
Q1
$730K Buy
23,307
+13,082
+128% +$410K ﹤0.01% 1621
2019
Q4
$344K Sell
10,225
-11,434
-53% -$385K ﹤0.01% 2464
2019
Q3
$643K Buy
21,659
+637
+3% +$18.9K ﹤0.01% 2026
2019
Q2
$720K Sell
21,022
-30,477
-59% -$1.04M ﹤0.01% 1996
2019
Q1
$1.69M Buy
51,499
+35,774
+227% +$1.18M ﹤0.01% 1338
2018
Q4
$374K Sell
15,725
-4,275
-21% -$102K ﹤0.01% 2114
2018
Q3
$670K Buy
20,000
+1,434
+8% +$48K ﹤0.01% 1937
2018
Q2
$544K Buy
+18,566
New +$544K ﹤0.01% 1989